# Sarcoma Oncology Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/sarcoma-oncology-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 52.3 |
| Citations | 83,664 |
| City | Santa Monica |
| Country | US |
| Description | Sarcoma Oncology Center is a research organisation in Santa Monica, US. OpenAlex records 991 works and 83,664 citations for it. 190 researchers list it as their most recent affiliation. |
| Homepage | https://sarcomaoncology.com |
| OpenAlex ID | https://openalex.org/I4210104185 |
| Region | California |
| Researchers | 190 |
| ROR ID | https://ror.org/01k15w004 |
| Type | healthcare |
| Works | 991 |

## University papers

- [Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications](https://scholariq.org/papers/gene-expression-patterns-of-breast-carcinomas-distinguish-tumor-subclasses-with/)
- [Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials](https://scholariq.org/papers/entrectinib-in-patients-with-advanced-or-metastatic-ntrk-fusion-positive-solid/)
- [Genome-wide analysis of DNA copy-number changes using cDNA microarrays](https://scholariq.org/papers/genome-wide-analysis-of-dna-copy-number-changes-using-cdna-microarrays/)
- [A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis](https://scholariq.org/papers/a-novel-gene-encoding-an-integral-membrane-protein-is-mutated-in-nephropathic/)
- [Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study](https://scholariq.org/papers/safety-and-efficacy-of-denosumab-for-adults-and-skeletally-mature-adolescents/)
- [Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-in-patients-with-advanced-or-metastatic/)
- [Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines](https://scholariq.org/papers/single-cell-profiling-of-circulating-tumor-cells-transcriptional-heterogeneity/)
- [Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial](https://scholariq.org/papers/lurbinectedin-as-second-line-treatment-for-patients-with-small-cell-lung-cancer/)
- [Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma](https://scholariq.org/papers/clinical-genomic-profiling-in-the-management-of-patients-with-soft-tissue-and/)

## University top topics

Showing 8 of 25.

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Vascular Tumors and Angiosarcomas](https://scholariq.org/topics/vascular-tumors-and-angiosarcomas/)
- [Bone Tumor Diagnosis and Treatments](https://scholariq.org/topics/bone-tumor-diagnosis-and-treatments/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cardiac tumors and thrombi](https://scholariq.org/topics/cardiac-tumors-and-thrombi/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.